FRI0110 The impact of seropositivity on the effectiveness of abatacept versus tnf inhibitors in rheumatoid arthritis. real life data from several european registries (THE PAN-ABA STUDY)

D. Courvoisier; D. Mongin; M. Hetland; K. Pavelka; C. Turesson; S. A. Bergstra; T. K. Kvien; M. J. Santos; V. Hernandez; F. Iannone; J.-e. Gottenberg; X. Mariette; S. Kubo; Y. Tanaka; D. Choquette; R. Ionescu; A. Finckh

doi:10.1136/annrheumdis-2018-eular.3312

FRI0110 The impact of seropositivity on the effectiveness of abatacept versus tnf inhibitors in rheumatoid arthritis. real life data from several european registries (THE PAN-ABA STUDY)

D. Courvoisier, D. Mongin, M. Hetland, K. Pavelka, C. Turesson, S. A. Bergstra, T. K. Kvien, M. J. Santos, V. Hernandez, F. Iannone, J.-e. Gottenberg, X. Mariette, S. Kubo, Y. Tanaka, D. Choquette, R. Ionescu, A. Finckh

Department of Clinical Medicine

Original language	English
Publication date	2018
Number of pages	2
DOIs	https://doi.org/10.1136/annrheumdis-2018-eular.3312
Publication status	Published - 2018

Access to Document

10.1136/annrheumdis-2018-eular.3312

599.2.full.pdfFinal published version, 330 KB

Cite this

Courvoisier, D., Mongin, D., Hetland, M., Pavelka, K., Turesson, C., Bergstra, S. A., Kvien, T. K., Santos, M. J., Hernandez, V., Iannone, F., Gottenberg, J., Mariette, X., Kubo, S., Tanaka, Y., Choquette, D., Ionescu, R., & Finckh, A. (2018). FRI0110 The impact of seropositivity on the effectiveness of abatacept versus tnf inhibitors in rheumatoid arthritis. real life data from several european registries (THE PAN-ABA STUDY). 599-600. https://doi.org/10.1136/annrheumdis-2018-eular.3312

Courvoisier, D, Mongin, D, Hetland, M, Pavelka, K, Turesson, C, Bergstra, SA, Kvien, TK, Santos, MJ, Hernandez, V, Iannone, F, Gottenberg, J, Mariette, X, Kubo, S, Tanaka, Y, Choquette, D, Ionescu, R & Finckh, A 2018, 'FRI0110 The impact of seropositivity on the effectiveness of abatacept versus tnf inhibitors in rheumatoid arthritis. real life data from several european registries (THE PAN-ABA STUDY)', pp. 599-600. https://doi.org/10.1136/annrheumdis-2018-eular.3312

@conference{056c302983354675b2df271cb17dba57,

title = "FRI0110 The impact of seropositivity on the effectiveness of abatacept versus tnf inhibitors in rheumatoid arthritis. real life data from several european registries (THE PAN-ABA STUDY)",

author = "D. Courvoisier and D. Mongin and M. Hetland and K. Pavelka and C. Turesson and Bergstra, {S. A.} and Kvien, {T. K.} and Santos, {M. J.} and V. Hernandez and F. Iannone and J.-e. Gottenberg and X. Mariette and S. Kubo and Y. Tanaka and D. Choquette and R. Ionescu and A. Finckh",

year = "2018",

doi = "10.1136/annrheumdis-2018-eular.3312",

language = "English",

pages = "599--600",

}

TY - ABST

T1 - FRI0110 The impact of seropositivity on the effectiveness of abatacept versus tnf inhibitors in rheumatoid arthritis. real life data from several european registries (THE PAN-ABA STUDY)

AU - Courvoisier, D.

AU - Mongin, D.

AU - Hetland, M.

AU - Pavelka, K.

AU - Turesson, C.

AU - Bergstra, S. A.

AU - Kvien, T. K.

AU - Santos, M. J.

AU - Hernandez, V.

AU - Iannone, F.

AU - Gottenberg, J.-e.

AU - Mariette, X.

AU - Kubo, S.

AU - Tanaka, Y.

AU - Choquette, D.

AU - Ionescu, R.

AU - Finckh, A.

PY - 2018

Y1 - 2018

U2 - 10.1136/annrheumdis-2018-eular.3312

DO - 10.1136/annrheumdis-2018-eular.3312

M3 - Conference abstract for conference

SP - 599

EP - 600

ER -